Delgocitinib cream is efficacious and well-tolerated for the treatment of adults with chronic hand eczema for up to 52 weeks.

Hand eczema may require diagnosis by a skin specialist called a dermatologist who can differentiate it from similar ...

Diagnosis, treatment, lifestyle changes ... Hand dermatitis (HD), also known as hand eczema, is a common dermatologic disorder (Warshaw, Lee, & Storrs, 2003). It is a frequent problem among ...

Eczema, a prevalent skin condition affecting millions worldwide, is characterized by dry, itching, and inflamed skin, frequently appearing on hands. Incorrect use of hand soap can exacerbate ...

Armstrong, MD, MPH, professor and chief of dermatology at the University of California, delgocitinib has brought a “new innovation” to the treatment of chronic hand eczema (CHE). A subset of ...

Treatment with delgocitinib cream ... related quality of life in patients with moderate to severe chronic hand eczema (CHE), with those receiving delgocitinib cream 20 mg/g showed greater ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

for the potential treatment of adults with moderate to severe chronic hand eczema. Results from the phase 3 DELTA 2 study showed that delgocitinib cream met its primary endpoint of statistically ...

Eczema, on the other hand, is a long-term, chronic condition that needs ongoing treatment and symptom management. Although the two conditions may have some similarities in their appearance ...

1 The findings from the post hoc analysis highlight that delgocitinib cream produced a strong treatment response across this subgroup of patients. A deep response, defined as a Hand Eczema Symptom ...